1,3-Cyclopentanediamine,cis- - MeSH

Search results

Items: 1 to 20 of 266

<< First< Prev

Page of 14

The following terms were not found in MeSH: Cyclopentanediamine, 3-Cyclopentanediamine.

Select item 680199001.

3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer

A non-peptide, kappa-opioid receptor agonist which has also been found to stimulate the release of adrenocorticotropin (ADRENOCORTICOTROPIC HORMONE) via the release of hypothalamic arginine vasopressin (ARGININE VASOPRESSIN) and CORTICOTROPIN-RELEASING HORMONE. (From J Pharmacol Exp Ther 1997;280(1):416-21)

Year introduced: 2002(1998)

Select item 680505572.

Catechol 2,3-Dioxygenase

Catalyzes the oxidation of catechol to 2-hydroxymuconate semialdehyde in the carbazole and BENZOATE degradation via HYDROXYLATION pathways. It also catalyzes the conversion of 3-methylcatechol to cis, cis-2-hydroxy-6-oxohept-2,4-dienoate in the TOLUENE and XYLENE degradation pathway. This enzyme was formerly characterized as EC 1.13.1.2.

Year introduced: 2006(1981)

Select item 680115203.

Protocatechuate-3,4-Dioxygenase

An enzyme that catalyzes the oxidation of protocatechuate to 3-carboxy-cis-cis-muconate in the presence of molecular oxygen. It contains ferric ion. EC 1.13.11.3.

Year introduced: 1991(1975)

Select item 670363614.

1-amino-1,3-dicarboxycyclopentane [Supplementary Concept]

RN given refers to (cis)-isomer

Date introduced: December 13, 1982

Select item 670305925.

3-methylfentanyl [Supplementary Concept]

RN given refers to parent cpd without isomeric designation

Date introduced: July 30, 1981

Select item 670653316.

1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline [Supplementary Concept]

RN given refers to parent cpd

Date introduced: September 13, 1990

Select item 670755017.

3-aminocyclopentane-1-carboxylic acid [Supplementary Concept]

structure given in first source; a selective GABA-A agonist; a cyclopentane analog of GABA; RN given for (trans)-isomer

Date introduced: August 4, 1992

Select item 670110768.

platinum(II) 1,2-diaminocyclohexane malonate [Supplementary Concept]

RN given refers to (SP-4-2-(trans))-isomer

Date introduced: January 1, 1976

Select item 670581199.

dichloro-1-hydroxy-3,4-diaminocyclohexane platinum complex [Supplementary Concept]

structure given in first source; RN given refers to the (1alpha,3beta,4beta)-isomer

Date introduced: February 1, 1989

Select item 6705670610.

3-phenyl-3-(N-piperidinyl)bicyclo(3.1.0)hexane [Supplementary Concept]

RN & structure given in first source; RN given refers to (cis)-isomer; RN for cpd without isomeric designation not available 9/88

Date introduced: September 1, 1988

Select item 202791011.

Oxaliplatin

An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.

Year introduced: 2019 (1981)

Select item 6748078212.

1-phenyl-3-(3-methoxy-2-propoxy-5-(4-(3,4,5-trimethoxyphenyl)-1,3-dithiolane-2-yl)phenyl)thiourea [Supplementary Concept]

increases production of nitric oxide; ZX-4 and ZX-5 are the (cis)- and (trans)-isomers, respectively; structure in first source

Date introduced: January 23, 2004

Select item 6800239213.

Catechin

An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms.

Year introduced: 1987(1977)

Select item 6707542114.

1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane [Supplementary Concept]

may be highly effective in treatment of estrogen-dependent breast cancer; structure given in first source; RN given refers to the (cis)-isomer